Compare Delta Air Lines, Inc. (DAL) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Delta Air Lines, Inc. vs Summit Therapeutics Inc — how do they compare? Delta Air Lines, Inc. trades at $90.5 (market cap $59.46B), while Summit Therapeutics Inc trades at $15.43 (market cap $12.06B). The key difference: Delta Air Lines, Inc. is far larger — about 4.9× Summit Therapeutics Inc's market cap, and Delta Air Lines, Inc. pays a 0.86% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| DAL | SMMT | |
|---|---|---|
Market Cap | $59.46B | $12.06B |
Sector | Industrials | Health |
52-Week High | $93.66 | $26.98 |
52-Week Low | $55.65 | $12.55 |
Enterprise Value | $74.77B | $11.39B |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Delta Air Lines, Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
